The $18.5 billion merger underscores the growth potential of telemedicine as the coronavirus pandemic accelerates the use of virtual health platforms.
An investor class action alleges the telemedicine company failed to disclose Mark Hirschhorn's "inappropriate relationship" with a subordinate.
